| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/10/2006 | US7118902 modified aggrecanases, nucleotides encoding such enzymes, and processes for producing these enzymes with improved stability; treatment of osteoarthritis |
| 10/10/2006 | US7118900 Forming functionally organized, spatially patterned, alternating current mediated, self supporting, organic polymer-microparticle thin films/hydrogels |
| 10/10/2006 | US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer |
| 10/10/2006 | US7118893 SCA7 gene and methods of use |
| 10/10/2006 | US7118892 Detection of preferential nucleotide sequence in sample; obtain sample containing nucleotide sequences, withdraw segment of sample and expose to amplification reaction, incubate with probe, detect amplified nucleotide sequences |
| 10/10/2006 | US7118881 Configured to define an interstitial space and contacting a glucose oxidase component; introducing glucose to the glucose oxidase component; and monitoring electrical response upon interstitial sorption of hydrogen gas; the glucose is preferably oxidized to gluconic acid |
| 10/10/2006 | US7118880 MONITOR PROTEIN C ANTICOAGULATION; ACTIVATE COAGULATION CASCADE, TRIGGER COAGULATION, INCUBATE, MEASURE ACTIVITY OF EXOGENOUS SUBSTRATE, COMPARE TO CONTROL; Bioassay for qualitative and/or quantitative determination of functional activity of components of protein c anticoagulant pathway |
| 10/10/2006 | US7118879 Obtaining a gene encoding a potential binding domain by random mutagenesis of a few predetermined codons, fusing it to a genetic element, causing the resulting chimeric expression product to be displayed on the outer surface of a cell/virus |
| 10/10/2006 | US7118878 Assaying in the presence of an organic compound that reduces luminescence not dependent on the presence of an analyte by at least 10 fold, and that reduces luminescence dependent on the presence of an analyte by less than 7 fold, and that has a C to S single or double bond or a C to Se double bond |
| 10/10/2006 | US7118877 Identifying enzyme modulators for treating neurodegenerative, autoimmune and tumor diseases |
| 10/10/2006 | US7118876 Detecting benign prostatic hyperplasia by assaying prostate tissue to determine amount of Breast Tumor Kinases (BRK/Sik) present |
| 10/10/2006 | US7118875 Analyte determination using a general purpose structure of an analytical element |
| 10/10/2006 | US7118873 Polynucleotides encoding cellular transporters and methods of use thereof |
| 10/10/2006 | US7118871 Reagents for monitoring nucleic acid amplification and methods of using same |
| 10/10/2006 | US7118870 Detection of fecal contamination using nucleic acid molecules that recognize bacterial 16S rDNA sequences |
| 10/10/2006 | US7118869 Genomic sequence of the 5-Lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma |
| 10/10/2006 | US7118868 Pretreatment Dna; amplification using polymerase primers; incubation in solution of hydrogen sulfite; polymerase chain reactions; brain disorders; skin disorders; bone disorders; antiinflammatory agents; headaches; sexual disorders |
| 10/10/2006 | US7118867 Quantitative multiplex PCR with high dynamic range |
| 10/10/2006 | US7118866 Heterodimeric receptor libraries using phagemids |
| 10/10/2006 | US7118865 Diagnosing autoimmune diseases via variances in gene expression patterns in peripheral blood mononuclear cells |
| 10/10/2006 | US7118864 Amplifiable probe |
| 10/10/2006 | US7118863 Methods for detecting NTR3 nucleic acids by hybridization |
| 10/10/2006 | US7118862 Induction of apoptosis by cellular stress |
| 10/10/2006 | US7118861 Conducting semiconductor layer; insulating or semi-insulating layer; single-stranded DNA probe directly adsorbed on one of the layers; conducting pads on the upper layer in electrical contact with the semiconductor layer; used to detect genetic disease mutations |
| 10/10/2006 | US7118860 Methods for detection of a target nucleic acid by capture |
| 10/10/2006 | US7118859 Methods for inhibiting HIV-1 infection |
| 10/10/2006 | US7118858 Marker for antidepressant therapy and methods related thereto |
| 10/10/2006 | US7118857 Performing a modified bioburden test on glucose polymer powder to detect Alicyclobacillus acidocaldarius and forming a solution of the powder; sterilizing; and adding a reagent from silkworm larvae plasma that is reactive with peptidoglycan to determine a peptidoglycan concentration |
| 10/10/2006 | US7118856 Enzyme catalyst; polypeptides; crystal structure |
| 10/10/2006 | US7118855 Based on pattern of active and deactivated areas of receptive material |
| 10/10/2006 | US7118854 PAK2: modulators of lymphocyte activation |
| 10/10/2006 | US7118853 Providing tumor sample; Detecting expression or activity of a gene encoding the polypeptide in tumor sample; classifying the tumor as belonging to a tumor subclass |
| 10/10/2006 | US7118738 Recombinant pox virus for immunization against MUC1 tumor-associated antigen |
| 10/10/2006 | US7118668 Electrochemical test sensor |
| 10/10/2006 | CA2277520C Nucleic acid sequencing |
| 10/10/2006 | CA2238964C Plants having mutant sequences that confer altered fatty acid profiles |
| 10/10/2006 | CA2192324C Recombinant virus and related method of quantitating same |
| 10/10/2006 | CA2119635C Method of geochemical prospecting |
| 10/08/2006 | CA2540736A1 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof |
| 10/07/2006 | CA2507021A1 Assay |
| 10/06/2006 | CA2602185A1 Enzymes and formulations for broad-specificity decontamination of chemical and biological warfare agents |
| 10/05/2006 | WO2006105540A2 Methods of identifying aberrant rna or rna targeted for cleavage by mirna or sirna |
| 10/05/2006 | WO2006105537A2 Human niemann pick c1-like 1 gene (npc1l1) polymorphisms and methods of use thereof |
| 10/05/2006 | WO2006105516A2 Compositions and methods for diagnosing and treating neuropsychiatric disorders |
| 10/05/2006 | WO2006105504A1 Apparatus and method for detecting microorganisms using flagged bacteriophage |
| 10/05/2006 | WO2006105487A1 Method for selectively blocking hemoglobin rna amplification |
| 10/05/2006 | WO2006105486A2 Novel tumor suppressor gene and compositions and methods for making and using the same |
| 10/05/2006 | WO2006105483A2 Mutant dna polymerases and methods of use |
| 10/05/2006 | WO2006105417A2 Compositions and methods for the identification, assessment, prevention, and therapy of neurological diseases, disorders and conditions |
| 10/05/2006 | WO2006105415A2 Methods and compositions for in situ detection of microorganisms on a surface |
| 10/05/2006 | WO2006105414A2 Apparatus and method for detecting microscopic organisms using microphage |
| 10/05/2006 | WO2006105409A2 Multiplex assay systems |
| 10/05/2006 | WO2006105360A1 Nanowire-based system for analysis of nucleic acids |
| 10/05/2006 | WO2006105329A2 Device for evaluating in vitro cell migration under flow conditions, and methods of use thereof |
| 10/05/2006 | WO2006105319A2 Assessment of cardiac disease by cec gene profile analysis |
| 10/05/2006 | WO2006105285A1 Circularizable nucleic acid probes and amplification methods |
| 10/05/2006 | WO2006105277A2 Eg1117 and eg307 polynucleotides and uses thereof |
| 10/05/2006 | WO2006105252A2 Diagnosis of chronic pulmonary obstructive disease and monitoring of therapy using gene expression analysis of peripheral blood cells |
| 10/05/2006 | WO2006105213A2 Methods and kits for detection of chromosome aneuploidy by high performance liquid chromatography with post-column fluorescence detection |
| 10/05/2006 | WO2006104991A2 Kits and methods for assessing antioxidant requirement of a human |
| 10/05/2006 | WO2006104912A2 C-met mutations in lung cancer |
| 10/05/2006 | WO2006104778A2 Compositions and methods for detecting protease activity |
| 10/05/2006 | WO2006104761A2 Unique sequence hybridization probes (usp) |
| 10/05/2006 | WO2006104586A2 Methods of diagnosis and treatment of metabolic disorders |
| 10/05/2006 | WO2006104486A1 Development of a real-time pcr assay for detection of pneumococcal dna and diagnosis of pneumococcal disease |
| 10/05/2006 | WO2006104477A1 Detection of truncation mutations in a large background of normal dna |
| 10/05/2006 | WO2006104474A2 A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells |
| 10/05/2006 | WO2006104381A1 Identification of beta-papillomavirus dna by type-specific reverse hybridization |
| 10/05/2006 | WO2006104370A1 Multiple snp for diagnosing colorectal cancer, microarray and kit comprising the same, and method of diagnosing colorectal cancer using the same |
| 10/05/2006 | WO2006104254A1 Method for screening of receptor-binding substance |
| 10/05/2006 | WO2006104200A1 Fluorescent protein |
| 10/05/2006 | WO2006104099A1 RORα PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
| 10/05/2006 | WO2006104035A1 Tripodal functional interface molecule for immobilization of biological molecule and device for detection of gene |
| 10/05/2006 | WO2006104031A1 Method of detecting mycoplasma |
| 10/05/2006 | WO2006103988A1 Method of evaluating external stimulus |
| 10/05/2006 | WO2006103920A1 Method of discriminating cancer and atypical cells and cell analyzer |
| 10/05/2006 | WO2006103442A2 Materials and methods relating to breast cancer classification |
| 10/05/2006 | WO2006103421A2 Method for predicting the response to receptor tyrosine kinase inhibitors |
| 10/05/2006 | WO2006103416A1 Assay for measuring asymmetric methylarginine in a biological sample |
| 10/05/2006 | WO2006103113A2 Method of screnning for the presence of a genetic defect associated with deep venous thrombosis |
| 10/05/2006 | WO2006103094A2 Method for treating a sample that contains biomolecules |
| 10/05/2006 | WO2006103039A1 Reverse transcription and amplification of rna with simultaneous degradation of dna |
| 10/05/2006 | WO2006102772A1 PRIMERS FOR AMPLIFICATION AND SEQUENCING OF EUBACTERIAL 16S rDNA FOR IDENTIFICATION |
| 10/05/2006 | WO2006102767A1 Tuberculosis vaccine and method for making same |
| 10/05/2006 | WO2006102755A1 Identification of a sterol acyltransferase gene |
| 10/05/2006 | WO2006102720A1 Isolation of inhibitor of ires-mediated translation |
| 10/05/2006 | WO2006102716A1 A method of diagnosis and treatment and agents useful for same |
| 10/05/2006 | WO2006102695A1 Identifying respiratory infectious organisms |
| 10/05/2006 | WO2006083566A3 Biosensor based on polymer cantilevers |
| 10/05/2006 | WO2006078267A3 Pathogen identification method |
| 10/05/2006 | WO2006075084A3 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and uses thereof |
| 10/05/2006 | WO2006073422A9 Activation of natural killer (nk) cells and methods of use |
| 10/05/2006 | WO2006071568A3 Methods, compositions, and kits for forming labeled polynucleotides |
| 10/05/2006 | WO2006065273A3 New human parvovirus |
| 10/05/2006 | WO2006062716A3 Methods and compositions for treating ocular disorders |
| 10/05/2006 | WO2006060429A3 Identification of variants in histone deacetylase 1 (hdac1) to predict drug response |
| 10/05/2006 | WO2006059247A3 VACCINES, COMPOSITIONS AND METHODS BASED ON STAPHYLOCOCCUS AUREUS IRON-REGULATED SURFACE DETERMINANTS IsdA, IsdB, and IsdC |
| 10/05/2006 | WO2006058263A3 Sensing phage-triggered ion cascade (septic) |
| 10/05/2006 | WO2006047510A3 METHODS AND COMPOSITIONS FOR FeLV DIAGNOSIS |
| 10/05/2006 | WO2006044045A3 Cryptosporidium hominis genes and gene products for chemotherapeutic, immunoprophylactic and diagnostic applications |